{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:50:33Z","timestamp":1791312633007,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016308","name":"Wuxi Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Commission of Health and Family Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.neulet.2021.135669","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T23:16:49Z","timestamp":1611271009000},"page":"135669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Altered mRNA expression levels of autophagy- and apoptosis-related genes in the FOXO pathway in schizophrenia patients treated with olanzapine"],"prefix":"10.1016","volume":"746","author":[{"given":"Shuguang","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengwei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0284-1287","authenticated-orcid":false,"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2021.135669_bib0005","article-title":"FOXO transcription factors: their clinical significance and regulation","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.neulet.2021.135669_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.ctdb.2017.10.006","article-title":"Regulation of FOXO factors in mammalian cells","volume":"127","author":"Brown","year":"2018","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.neulet.2021.135669_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-8900-3_1","article-title":"Introduction to FOXO biology","volume":"1890","author":"Link","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neulet.2021.135669_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.ctdb.2017.10.002","article-title":"FOXO in neural cells and diseases of the nervous system","volume":"127","author":"Santo","year":"2018","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.neulet.2021.135669_bib0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/1567202614666171116102911","article-title":"Forkhead transcription factors: formulating a FOXO target for cognitive loss","volume":"14","author":"Maiese","year":"2017","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.neulet.2021.135669_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12733","article-title":"FoxO1 in dopaminergic neurons regulates energy homeostasis and targets tyrosine hydroxylase","volume":"7","author":"Doan","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neulet.2021.135669_bib0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.neuropharm.2015.08.020","article-title":"Forkhead box O transcription factors as possible mediators in the development of major depression","volume":"99","author":"Wang","year":"2015","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.neulet.2021.135669_bib0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1101\/gad.309625.117","article-title":"Brain-gut communications via distinct neuroendocrine signals bidirectionally regulate longevity in C. Elegans","volume":"32","author":"Zhang","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.neulet.2021.135669_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00702-014-1362-4","article-title":"Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression","volume":"123","author":"Naoi","year":"2016","journal-title":"J. Neural. Transm. (Vienna)."},{"key":"10.1016\/j.neulet.2021.135669_bib0050","first-page":"1","article-title":"Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles","volume":"12","author":"Yao","year":"2020","journal-title":"Autophagy."},{"key":"10.1016\/j.neulet.2021.135669_bib0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10974-019-09512-2","article-title":"Neuregulin-1\u03b2 attenuates sepsis-induced diaphragm atrophy by activating the PI3K\/Akt signaling pathway","volume":"40","author":"Wu","year":"2019","journal-title":"J. Muscle Res. Cell. Motil."},{"key":"10.1016\/j.neulet.2021.135669_bib0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1503\/jpn.150332","article-title":"Bipolar disorder risk gene FOXO6 modulates negative symptoms in schizophrenia: a neuroimaging genetics study","volume":"42","author":"Shenker","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neulet.2021.135669_bib0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.biopsych.2008.08.005","article-title":"Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation","volume":"65","author":"Polter","year":"2009","journal-title":"Biol. sychiatry."},{"key":"10.1016\/j.neulet.2021.135669_bib0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jad.2011.04.031","article-title":"Genetic variations in FOXO3A are associated with bipolar disorder without confering vulnerability for suicidal behavior","volume":"133","author":"Magno","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neulet.2021.135669_bib0075","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/s41380-017-0002-4","article-title":"FoxO1, A2M, and TGF-\u03b21: three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analyses","volume":"23","author":"Cattaneo","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2021.135669_bib0080","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s12035-016-9904-4","article-title":"The aypical antipsychotic agent, clozapine, protects against corticosterone-induced death of PC12 cells by regulating the Akt\/FoxO3a signaling pathway","volume":"54","author":"Zeng","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neulet.2021.135669_bib0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/WNR.0b013e3283623725","article-title":"Lithium normalizes amphetamine-induced changes in striatal FoxO1 phosphorylation and behaviors in rats","volume":"24","author":"Zheng","year":"2013","journal-title":"Neuroreport."},{"key":"10.1016\/j.neulet.2021.135669_bib0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/cn100010p","article-title":"Antipsychotic drugs activate the C. Elegans akt pathway via the DAF-2 insulin\/IGF-1 receptor","volume":"1","author":"Weeks","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neulet.2021.135669_bib0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/CBM-160196","article-title":"E2F3 transcription fator: a promising biomarker in lung cancer","volume":"19","author":"AI Ahmed","year":"2017","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.neulet.2021.135669_bib0100","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-020-01585-w","article-title":"Integrative in silico analysis of genome-wide DNA methylation profiles in schizophrenia","author":"Forero","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2021.135669_bib0105","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41419-019-2174-0","article-title":"Defective neurogenesis and schizophrenia-like behavior in PARP-1-deficient mice","volume":"10","author":"Hong","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neulet.2021.135669_bib0110","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/npp.2016.271","article-title":"Cacna1c in the prefrontal cortex regulates depression-related behaviors via REDD1","volume":"42","author":"Kabir","year":"2017","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.neulet.2021.135669_bib0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ajmg.b.32236","article-title":"Adult neuropsychiatric expression and familial segregation of 2q13 duplications","volume":"165B","author":"Costain","year":"2014","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neulet.2021.135669_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156624","article-title":"Sex differences in serum markers of major depressive disorder in the netherlands study of depression and anxiety (NESDA)","volume":"11","author":"Ramsey","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2021.135669_bib0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.psychres.2016.07.010","article-title":"The mRNA expression of DRD2, PI3KCB, and AKT1 in the blood of acute schizophrenia patients","volume":"243","author":"Liu","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2021.135669_bib0130","doi-asserted-by":"crossref","first-page":"86515","DOI":"10.18632\/oncotarget.21230","article-title":"Correlation of DRD2 mRNA expression levels with deficit syndrome severity in chronic schizophrenia patients receiving clozapine treatment","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neulet.2021.135669_bib0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1871527317666180605120244","article-title":"A longitudinal study of alterations of S100B, sRAGE and Fas Ligand in association to olanzapine medication in a sample of first episode patients with schizophrenia","volume":"17","author":"Gerasimou","year":"2018","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neulet.2021.135669_bib0140","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.4161\/15548627.2014.984270","article-title":"Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine","volume":"10","author":"Vucicevic","year":"2014","journal-title":"Autophagy."},{"key":"10.1016\/j.neulet.2021.135669_bib0145","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1242\/jcs.185009","article-title":"Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer\u2019s disease models","volume":"129","author":"Shi","year":"2016","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.neulet.2021.135669_bib0150","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/hmg\/ddt164","article-title":"De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer\u2019s disease","volume":"22","author":"Wong","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2021.135669_bib0155","doi-asserted-by":"crossref","first-page":"38952","DOI":"10.18632\/oncotarget.5731","article-title":"The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2\/Akt\/FOXO3a signaling","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.neulet.2021.135669_bib0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lfs.2017.11.030","article-title":"The regulation of FOXO1 and its role in disease progression","volume":"193","author":"Xing","year":"2018","journal-title":"Life Sci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:37:57Z","timestamp":1759610277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394021000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"alternative-id":["S0304394021000471"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135669","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered mRNA expression levels of autophagy- and apoptosis-related genes in the FOXO pathway in schizophrenia patients treated with olanzapine","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"135669"}}